Literature DB >> 1224161

[Analysis of disorders of the principal pathways of calcium metabolism in Paget's disease. Effects of calcitonin administration. 26 cases].

G Coutris, J Cayla, J Rondier, J N Talbot, J P Bonvarlet, G Milhaud.   

Abstract

Analysis of the principal routes of calcium metabolism by means of calcium-45 in 26 patients suffering from Paget's diseases sometimes showed, in agreement with data from the literature, a considerable increase in the common stocks of calcium in 25 cases, and an elevation in the anabolism (Vo+) in bone and in the catabolism (Vo-) in bone in all cases. The calcium balance was sometimes equal, but often clearly positive (10 cases) or negative (10 cases) and the level intestinal absorption of calcium was usually within the normal limits. An elevation in the endogenous fecal calcium (Vf) noted in half of the cases, although no value was below normal, seemed to represent an metabolic anomaly of abnormally high frequency in patients with Paget's disease, even though this fact has never been emphasized before. Statistically significant correlations were shown between the values of different kinetic and metabolic parameters in the group of patients studied. A second kinetic study carried out after several weeks of treatment with porcine calcitonin showed a statistically significant diminution in the values of Vo +, Vo -, endogenous fecal calcium, calciuria, hydroxyprolinuria, and in alkaline phosphatasaemia, as well as significant variations in the calcium balance in a positive direction. The common calcium stocks did not show a significant diminution, contrary to the findings of other authors. The level of intestinal absorption of calcium increased more often than it decreased, but the magnitude of the variations was slightly less than the level of statistical significance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1224161

Source DB:  PubMed          Journal:  Rev Rhum Mal Osteoartic        ISSN: 0035-2659


  5 in total

Review 1.  Treatment of patients with Paget's disease of bone.

Authors:  C Roux; M Dougados
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

2.  Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.

Authors:  P D Delmas; B Demiaux; L Malaval; M C Chapuy; P J Meunier
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

3.  An economic evaluation of tiludronic acid treatment in Paget's disease of bone.

Authors:  A Lafuma; F Fagnani; P J Meunier
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

4.  Decreasing severity of Paget's disease of bone in northern Italy over the last two decades: results of a monocentric study on 391 patients.

Authors:  M Varenna; F Zucchi; C Crotti; M Manara; R Caporali
Journal:  Osteoporos Int       Date:  2021-02-22       Impact factor: 4.507

5.  Influence Of Angiogenic Mediators And Bone Remodelling In Paget´s Disease Of Bone.

Authors:  Isabel Fuentes-Calvo; Ricardo Usategui-Martín; Ismael Calero-Paniagua; Cristina Moledo-Pouso; Luis García-Ortiz; Javier Del Pino-Montes; Rogelio González-Sarmiento; Carlos Martínez-Salgado
Journal:  Int J Med Sci       Date:  2018-07-30       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.